Cardiomyopathy: A Systematic Review of Disease-Causing Mutations in Myosin Heavy Chain 7 and Their Phenotypic Manifestations

Background:Mutations in myosin heavy chain 7 (MYH7) commonly cause cardiomyopathy. However, the relationship between mutation location, cardiomyopathy type, change in amino acid composition and disease severity is poorly understood. This systematic review aims to provide, on a large scale, important insights into the role mutations in MYH7 play in cardiomyopathy. Methods: The literature was searched from 1966 to March 2009. The mutation location, type of mutation and disease type and severity were documented. When the severity of disease was known, the change in charge and hydropathy of the mutation was determined. Where appropriate, either a χ2 test was used or a relative risk ratio was calculated in order to evaluate the data. Results:The data presented in this study demonstrate that there are proportionately more mutations in the head and neck regions of this gene than in the tail. Importantly, mutations in the head of the gene, those that cause large changes in the hydropathy of the amino acid and non-conservative mutations are more likely to lead to a severe phenotype. Conclusions: This study suggests that mutation location in the MYH7 gene and changes in amino acid composition can have a negative impact on the disease outcome in individuals with cardiomyopathy.

[1]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[2]  S. Solomon,et al.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. , 1994, The Journal of clinical investigation.

[3]  Nicole M. Johnson,et al.  Familial Hypertrophic Cardiomyopathy Associated with Cardiac β-Myosin Heavy Chain and Troponin I Mutations , 2008, Pediatric Cardiology.

[4]  T. Wilczok,et al.  Three novel mutations in exon 21 encoding beta-cardiac myosin heavy chain. , 2003, Journal of applied genetics.

[5]  H. Watkins,et al.  The genetics of hypertrophic cardiomyopathy: Teare redux , 2007, Heart.

[6]  T. M. Yelbuz,et al.  Isolated noncompaction of the left ventricular myocardium , 2007, Clinical Research in Cardiology.

[7]  J B Patlak,et al.  Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay. , 2007, American journal of physiology. Heart and circulatory physiology.

[8]  I. Rayment,et al.  Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  I. Schlichting,et al.  Crystal structures of human cardiac beta-myosin II S2-Delta provide insight into the functional role of the S2 subfragment. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Seidman,et al.  Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[11]  D. Root,et al.  High flexibility of the actomyosin crossbridge resides in skeletal muscle myosin subfragment-2 as demonstrated by a new single molecule assay. , 2005, Journal of structural biology.

[12]  F J Schoen,et al.  Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene. , 1999, The Journal of clinical investigation.

[13]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[14]  J. Seidman,et al.  Altered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.

[15]  P. Kaufmann,et al.  Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy , 2001, Heart.

[16]  D. Nozdrenko,et al.  PACKING OF MYOSIN MOLECULES IN MUSCLE THICK FILAMENTS , 2000, Cell biology international.

[17]  M. Golubenko,et al.  Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy. , 2003, Journal of molecular and cellular cardiology.

[18]  T. M. Yelbuz,et al.  Isolated noncompaction of the left ventricular myocardium -- a review of the literature two decades after the initial case description. , 2007, Clinical research in cardiology : official journal of the German Cardiac Society.

[19]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[20]  Ferhaan Ahmad,et al.  Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function , 2006, Proceedings of the National Academy of Sciences.

[21]  Christine E. Seidman,et al.  α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.

[22]  D. Manstein,et al.  Molecular mechanism of actomyosin-based motility , 2005, Cellular and Molecular Life Sciences CMLS.

[23]  S. Henikoff,et al.  Predicting the effects of amino acid substitutions on protein function. , 2006, Annual review of genomics and human genetics.

[24]  A. Blamire,et al.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. , 2003, Journal of the American College of Cardiology.

[25]  N. Epstein The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains. , 1998, Advances in experimental medicine and biology.

[26]  A. Tajik,et al.  Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[27]  Chun-yan Fu,et al.  Worse Prognosis with Gene Mutations of Beta‐myosin Heavy Chain than Myosin‐Binding Protein C in Chinese Patients with Hypertrophic Cardiomyopathy , 2008, Clinical cardiology.

[28]  J. Huhta,et al.  Fifteen-year-old boy with stress-induced arrhythmia and sudden death. , 2002, American journal of medical genetics.

[29]  Y. Lecarpentier,et al.  Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties. , 2004, Journal of molecular and cellular cardiology.

[30]  W. Roberts,et al.  Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. , 1982, Circulation.

[31]  S. Reiken,et al.  Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs is associated with calstabin2 deficiency. , 2008, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

[32]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[33]  Robert H. Anderson,et al.  Developmental patterning of the myocardium , 2000, The Anatomical record.

[34]  G Thiene,et al.  The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. , 1994, Human molecular genetics.

[35]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[36]  L. Fananapazir,et al.  Differences in Clinical Expression of Hypertrophic Cardiomyopathy Associated With Two Distinct Mutations in the β‐Myosin Heavy Chain Gene: A 908Leu→Val Mutation and a 403Arg→gGln Mutation , 1992, Circulation.

[37]  A. Marian,et al.  Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations. , 1995, European heart journal.

[38]  E D Wigle,et al.  Mutations of the β myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis , 2003, Heart.

[39]  A. Marian,et al.  Sudden cardiac death in hypertrophic cardiomyopathy , 1995 .

[40]  T. Kishimoto,et al.  A novel deletion mutation in the beta-myosin heavy chain gene found in Japanese patients with hypertrophic cardiomyopathy. , 1995, Journal of molecular and cellular cardiology.

[41]  M. Komajda,et al.  Genotype‐phenotype analysis in four families with mutations in β‐myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy , 1998, Human mutation.

[42]  J. Seidman,et al.  Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. , 2008, American journal of physiology. Heart and circulatory physiology.

[43]  D. Kass,et al.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. , 1999, The Journal of clinical investigation.

[44]  J. Perloff,et al.  Isolated noncompaction of left ventricular myocardium. A study of eight cases. , 1990, Circulation.

[45]  P. Brink,et al.  Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations. , 1995, British heart journal.

[46]  J. Seidman,et al.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.

[47]  S. Lowey,et al.  Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy. , 2002, Trends in cardiovascular medicine.

[48]  Jeroen J. Bax,et al.  Non-compaction cardiomyopathy-echocardiographic diagnosis. , 2002, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[49]  H. Rakowski,et al.  Mutations of the β myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis , 2003 .

[50]  G. Guzman,et al.  Myosin essential light chain in health and disease. , 2007, American journal of physiology. Heart and circulatory physiology.

[51]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[52]  G. Phillips,et al.  Tropomyosin crystal structure and muscle regulation. , 1986, Journal of molecular biology.

[53]  Frederick J. Schoen,et al.  A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.

[54]  Pascale Richard,et al.  Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy , 1998, Journal of Molecular Medicine.

[55]  A. Tajik,et al.  Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. , 2002, Journal of the American College of Cardiology.

[56]  F. Berger,et al.  Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction , 2008, Circulation.

[57]  L. Fananapazir,et al.  Genotype-Phenotpe Correlations in Hypertrophic Cardiomyopathy Insights Provided by Comparisons of Kindreds With Distinct and Identical j3-Myosin Heavy Chain Gene Mutations , 2005 .

[58]  Jeffrey A. Towbin,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy Causing Sudden Cardiac Death in Boxer Dogs: A New Animal Model of Human Disease , 2004, Circulation.

[59]  K. Meurs,et al.  Molecular evaluation of five cardiac genes in Doberman Pinschers with dilated cardiomyopathy. , 2008, American journal of veterinary research.

[60]  R. Knight,et al.  Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. , 2008, Trends in cardiovascular medicine.

[61]  Robert H. Anderson Ventricular non-compaction--a frequently ignored finding? , 2007, European heart journal.

[62]  R A Milligan,et al.  Structure of the actin-myosin complex and its implications for muscle contraction. , 1993, Science.

[63]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.

[64]  J. Murray,et al.  Molecular control mechanisms in muscle contraction. , 1973, Physiological reviews.

[65]  I. Schlichting,et al.  Crystal structures of human cardiac β-myosin II S2-Δ provide insight into the functional role of the S2 subfragment , 2006, Proceedings of the National Academy of Sciences.

[66]  M. Matsuzaki,et al.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.

[67]  A. Børglum,et al.  Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.

[68]  R. Dietz,et al.  Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy , 2005, Journal of Molecular Medicine.

[69]  K. Meurs,et al.  Analysis of 8 sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy. , 2009, Journal of veterinary internal medicine.

[70]  C. Gille,et al.  Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. , 2002, Biochemical and biophysical research communications.

[71]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[72]  M. Quiñones,et al.  Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy. , 2004, Journal of molecular and cellular cardiology.

[73]  L. Leinwand,et al.  Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. , 1998, Biophysical journal.

[74]  Pamela R. Fain,et al.  α-Myosin Heavy Chain: A Sarcomeric Gene Associated With Dilated and Hypertrophic Phenotypes of Cardiomyopathy , 2005, Circulation.

[75]  J. Seidman,et al.  Gene Mutations in Apical Hypertrophic Cardiomyopathy , 2005, Circulation.

[76]  P. Rogan,et al.  A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. , 1994, Human molecular genetics.

[77]  H. Watkins,et al.  Mutations of the Light Meromyosin Domain of the &bgr;-Myosin Heavy Chain Rod in Hypertrophic Cardiomyopathy , 2002, Circulation research.

[78]  I. Rayment,et al.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.

[79]  A. Tajik,et al.  Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[80]  J. Seidman,et al.  Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. , 2000, Circulation research.

[81]  Niels Volkmann,et al.  The R403Q Myosin Mutation Implicated in Familial Hypertrophic Cardiomyopathy Causes Disorder at the Actomyosin Interface , 2007, PloS one.

[82]  L. Leinwand,et al.  Morphological and Functional Alterations in Ventricular Myocytes From Male Transgenic Mice With Hypertrophic Cardiomyopathy , 2004, Circulation research.

[83]  J. Seidman,et al.  The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.

[84]  S. Morimoto Sarcomeric proteins and inherited cardiomyopathies. , 2008, Cardiovascular research.

[85]  SabineKlaassen,et al.  Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction , 2008 .

[86]  A. Børglum,et al.  α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy , 1999 .

[87]  A. Bozio,et al.  A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy. , 2008, Congenital heart disease.

[88]  D. Fatkin,et al.  Molecular mechanisms of inherited cardiomyopathies. , 2002, Physiological reviews.